L W K Chang1, K L Buising2,3, C J Jeremiah3, K Cronin4, Y S Poy Lorenzo5, B P Howden6, J Kwong6, J Cocks7, A Blood7, J Greenough7, M J Waters4. 1. Department of Microbiology, Dorevitch Pathology, Melbourne, Victoria, Australia. 2. Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia. 3. Infectious Diseases Unit, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia. 4. Department of Microbiology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia. 5. Pharmacy Department, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia. 6. Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne, at The Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. 7. Infection Prevention and Control Unit, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
Abstract
BACKGROUND: Carbapenems are traditionally reserved as the last line of defence for treatment of serious infections with multiresistant Gram-negative bacilli. Reports of Klebsiella pneumoniae carbapenemase (KPC)-producing organisms have been emerging globally, but rare in Australasia to date. We describe an outbreak of KPC-2 producing K. pneumoniae at an Australian hospital. METHODS: After initial detection in October 2012, a retrospective review of patients with meropenem-resistant K. pneumoniae to June 2012, and ongoing prospective surveillance, was undertaken. Included patients were admitted to the hospital after June 2012 and had meropenem-resistant K. pneumoniae isolated from any site. Available isolates underwent detection of the KPC-2 gene by polymerase chain reaction and molecular typing was performed to determine genetic relatedness between isolates. Point-prevalence screening was performed on selected wards to detect asymptomatic carriage. Infection control procedures were implemented to contain the outbreak. RESULTS: Ten cases were identified in the initial cluster. Eight were localised to a single inpatient ward. Point-prevalence screening revealed one extra case. After temporary containment, re-emergence of KPC-producing isolates was observed post October 2013 with 18 further cases identified. Four K. pneumoniae isolates in the 2012 cluster and 16 from the 2013-2014 cluster were referred for further testing. All carried the KPC-2 beta-lactamase gene. The 2012 isolates were genetically similar to the 2014 isolates. CONCLUSION: KPC-2 mediated resistance is an emerging threat in Australia. The re-emergence of KPC despite initial containment emphasises the need for constant vigilance in the microbiology laboratory and ongoing maintenance of infection control and antimicrobial stewardship activity.
BACKGROUND:Carbapenems are traditionally reserved as the last line of defence for treatment of serious infections with multiresistant Gram-negative bacilli. Reports of Klebsiella pneumoniae carbapenemase (KPC)-producing organisms have been emerging globally, but rare in Australasia to date. We describe an outbreak of KPC-2 producing K. pneumoniae at an Australian hospital. METHODS: After initial detection in October 2012, a retrospective review of patients with meropenem-resistant K. pneumoniae to June 2012, and ongoing prospective surveillance, was undertaken. Included patients were admitted to the hospital after June 2012 and had meropenem-resistant K. pneumoniae isolated from any site. Available isolates underwent detection of the KPC-2 gene by polymerase chain reaction and molecular typing was performed to determine genetic relatedness between isolates. Point-prevalence screening was performed on selected wards to detect asymptomatic carriage. Infection control procedures were implemented to contain the outbreak. RESULTS: Ten cases were identified in the initial cluster. Eight were localised to a single inpatient ward. Point-prevalence screening revealed one extra case. After temporary containment, re-emergence of KPC-producing isolates was observed post October 2013 with 18 further cases identified. Four K. pneumoniae isolates in the 2012 cluster and 16 from the 2013-2014 cluster were referred for further testing. All carried the KPC-2 beta-lactamase gene. The 2012 isolates were genetically similar to the 2014 isolates. CONCLUSION:KPC-2 mediated resistance is an emerging threat in Australia. The re-emergence of KPC despite initial containment emphasises the need for constant vigilance in the microbiology laboratory and ongoing maintenance of infection control and antimicrobial stewardship activity.
Authors: Alex Agyekum; Alicia Fajardo-Lubián; Xiaoman Ai; Andrew N Ginn; Zhiyong Zong; Xuejun Guo; John Turnidge; Sally R Partridge; Jonathan R Iredell Journal: J Clin Microbiol Date: 2016-02-24 Impact factor: 5.948
Authors: Fabrizio Spagnolo; Pierre Cristofari; Nicholas P Tatonetti; Lev R Ginzburg; Daniel E Dykhuizen Journal: ISME J Date: 2018-07-25 Impact factor: 10.302
Authors: M L Cristina; M Sartini; G Ottria; E Schinca; N Cenderello; M P Crisalli; P Fabbri; G Lo Pinto; D Usiglio; A M Spagnolo Journal: J Prev Med Hyg Date: 2016-09
Authors: Jason C Kwong; Courtney R Lane; Finn Romanes; Anders Gonçalves da Silva; Marion Easton; Katie Cronin; Mary Jo Waters; Takehiro Tomita; Kerrie Stevens; Mark B Schultz; Sarah L Baines; Norelle L Sherry; Glen P Carter; Andre Mu; Michelle Sait; Susan A Ballard; Torsten Seemann; Timothy P Stinear; Benjamin P Howden Journal: PeerJ Date: 2018-01-03 Impact factor: 2.984
Authors: Norelle L Sherry; Courtney R Lane; Jason C Kwong; Mark Schultz; Michelle Sait; Kerrie Stevens; Susan Ballard; Anders Gonçalves da Silva; Torsten Seemann; Claire L Gorrie; Timothy P Stinear; Deborah A Williamson; Judith Brett; Annaliese van Diemen; Marion Easton; Benjamin P Howden Journal: J Clin Microbiol Date: 2019-08-26 Impact factor: 5.948
Authors: Leah W Roberts; Patrick N A Harris; Brian M Forde; Nouri L Ben Zakour; Elizabeth Catchpoole; Mitchell Stanton-Cook; Minh-Duy Phan; Hanna E Sidjabat; Haakon Bergh; Claire Heney; Jayde A Gawthorne; Jeffrey Lipman; Anthony Allworth; Kok-Gan Chan; Teik Min Chong; Wai-Fong Yin; Mark A Schembri; David L Paterson; Scott A Beatson Journal: Nat Commun Date: 2020-01-24 Impact factor: 14.919
Authors: Andrew A Mahony; Andrew H Buultjens; Susan A Ballard; Elizabeth A Grabsch; Shirley Xie; Torsten Seemann; Rhonda L Stuart; Despina Kotsanas; Allen Cheng; Helen Heffernan; Sally A Roberts; Geoffrey W Coombs; Narin Bak; John K Ferguson; Glen C Carter; Benjamin P Howden; Timothy P Stinear; Paul D R Johnson Journal: Antimicrob Resist Infect Control Date: 2018-03-22 Impact factor: 4.887